Rostral anterior cingulate activity in major depressive disorder: state or trait marker of responsiveness to medication?
- PMID: 23686030
- DOI: 10.1176/appi.neuropsych.11110330
Rostral anterior cingulate activity in major depressive disorder: state or trait marker of responsiveness to medication?
Abstract
High rostral anterior cingulate cortex (rACC) activity has been shown to predict antidepressant treatment response; however, it is unclear whether this is a fixed versus variable marker of responsiveness. The authors measured rACC theta current density in 22 subjects 5 weeks before and again immediately before 5 weeks of blinded treatment with sertraline. Mixed-effects regression analysis found that the relationship between response and rACC activity depended significantly on the timing of the rACC assessment; rACC activity measured immediately before treatment was a significantly better predictor of response. rACC activity may constitute a variable "state" indicator of responsiveness to antidepressants.
Similar articles
-
Frontal and rostral anterior cingulate (rACC) theta EEG in depression: implications for treatment outcome?Eur Neuropsychopharmacol. 2015 Aug;25(8):1190-200. doi: 10.1016/j.euroneuro.2015.03.007. Epub 2015 Apr 20. Eur Neuropsychopharmacol. 2015. PMID: 25936227 Clinical Trial.
-
Pretreatment Rostral Anterior Cingulate Cortex Theta Activity in Relation to Symptom Improvement in Depression: A Randomized Clinical Trial.JAMA Psychiatry. 2018 Jun 1;75(6):547-554. doi: 10.1001/jamapsychiatry.2018.0252. JAMA Psychiatry. 2018. PMID: 29641834 Free PMC article. Clinical Trial.
-
Rostral anterior cingulate cortex activity and early symptom improvement during treatment for major depressive disorder.Psychiatry Res. 2011 Jun 30;192(3):188-94. doi: 10.1016/j.pscychresns.2010.12.007. Epub 2011 May 4. Psychiatry Res. 2011. PMID: 21546222 Free PMC article. Clinical Trial.
-
Frontocingulate dysfunction in depression: toward biomarkers of treatment response.Neuropsychopharmacology. 2011 Jan;36(1):183-206. doi: 10.1038/npp.2010.166. Epub 2010 Sep 22. Neuropsychopharmacology. 2011. PMID: 20861828 Free PMC article. Review.
-
Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD.Eur Neuropsychopharmacol. 2009 Jan;19(1):34-40. doi: 10.1016/j.euroneuro.2008.08.009. Epub 2008 Sep 26. Eur Neuropsychopharmacol. 2009. PMID: 18823760 Review.
Cited by
-
A review of critical brain oscillations in depression and the efficacy of transcranial magnetic stimulation treatment.Front Psychiatry. 2023 May 16;14:1073984. doi: 10.3389/fpsyt.2023.1073984. eCollection 2023. Front Psychiatry. 2023. PMID: 37260762 Free PMC article. Review.
-
Resting and TMS-EEG markers of treatment response in major depressive disorder: A systematic review.Front Hum Neurosci. 2022 Aug 4;16:940759. doi: 10.3389/fnhum.2022.940759. eCollection 2022. Front Hum Neurosci. 2022. PMID: 35992942 Free PMC article.
-
Importance of test-retest reliability for promoting fMRI based screening and interventions in major depressive disorder.Transl Psychiatry. 2021 Jul 10;11(1):387. doi: 10.1038/s41398-021-01507-3. Transl Psychiatry. 2021. PMID: 34247184 Free PMC article.
-
Frontal theta and posterior alpha in resting EEG: A critical examination of convergent and discriminant validity.Psychophysiology. 2020 Feb;57(2):e13483. doi: 10.1111/psyp.13483. Epub 2019 Oct 2. Psychophysiology. 2020. PMID: 31578740 Free PMC article.
-
Dissociative states in borderline personality disorder and their relationships to psychotropic medication.Neuropsychiatr Dis Treat. 2018 Nov 23;14:3253-3257. doi: 10.2147/NDT.S179091. eCollection 2018. Neuropsychiatr Dis Treat. 2018. PMID: 30538483 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical